AUTL — Autolus Therapeutics plc
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1730463 ·
Last close
$1.61
Market Cap
$428.49M
52W High
$1.95
52W Low
$1.38
ADV30
1,212,617
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 26,218,000 | 1,650,000 | -59,513,000 | -71,598,000 | 527,065,000 | 130,925,000 | 418,239,000 |
| Dec 2025 | 24,289,000 | -1,041,000 | -72,469,000 | -90,332,000 | 589,068,000 | 104,132,000 | 410,939,000 |
| Sep 2025 | 21,194,000 | -7,449,000 | -71,621,000 | -79,118,000 | 661,947,000 | 86,124,000 | 396,495,000 |
| Jun 2025 | 20,923,000 | -3,522,000 | -61,217,000 | -47,917,000 | 720,981,000 | 123,825,000 | 374,517,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-273,320,000
Investing CF
$314,156,000
Financing CF
$-6,401,000
CapEx
$-30,705,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.01
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,458,350,000
Inventory
$33,233,000
Receivables
$86,256,000
ST Investments
$98,509,000
EBIT TTM
$-257,573,000
Pretax Income TTM
$-288,356,000
Interest Exp TTM
$54,623,000
Analysts
9
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,078,500
EBITDA
$-68,942,608
Free Cash Flow
—
Enterprise Value
$-150,920,384
Total Cash
$217,450,000
Total Debt
$0
Shares Out
266,143,286
Trailing EPS
$-1.09
Book Value
$5.91
ROE
-29.6%
ROA
-22.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 75,388,000 | -270,544,000 | -287,528,000 | 589,068,000 | 410,939,000 | — | -283,568,000 |
| Dec 2024 | 10,120,000 | -241,426,000 | -220,662,000 | 782,725,000 | 355,400,000 | — | -206,271,000 |
| Dec 2023 | 1,698,000 | -175,528,000 | -208,383,000 | 375,381,000 | 263,907,000 | — | -145,587,000 |
| Dec 2022 | 6,194,000 | -142,893,000 | -148,839,000 | 490,274,000 | 191,600,000 | — | -112,308,000 |
TTM Snapshot
Revenues TTM
$3,811,000
NetIncome TTM
$-170,710,000
OpCashFlow TTM
$0
Assets (Latest)
$782,725,000
Forward EPS
$-0.60
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CMPX | Compass Therapeutics, Inc. | $419.60M | $2.33 | — |
| XFOR | X4 Pharmaceuticals, Inc | $415.95M | $4.41 | — |
| CCCC | C4 Therapeutics, Inc. | $448.90M | $4.06 | — |
| IPSC | Century Therapeutics, Inc. | $405.80M | $2.25 | — |
| ARTV | Artiva Biotherapeutics, Inc. | $468.39M | $9.64 | — |
News headlines (Yahoo Finance, 1h cache)
European Equities Traded in the US as American Depositary Receipts Decline Sharply in Wednesday Trading
2026-07-08 15:09 · Yahoo
European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading
2026-07-07 15:07 · Yahoo
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading
2026-07-02 15:13 · Yahoo
Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-07-01 20:05 · Yahoo
Autolus Therapeutics to Participate in Upcoming Investor Conference
2026-06-25 11:00 · Yahoo
European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
2026-06-24 15:15 · Yahoo
Autolus Therapeutics (AUTL) Stock Sees Split Analyst Revisions After Early Aucatyzl Launch Signals
2026-06-24 11:11 · Yahoo
Why Autolus Therapeutics (AUTL) Looks Less Speculative as AUCATZYL Revenue Builds
2026-06-17 15:16 · Yahoo
European Equities Traded in the US as American Depositary Receipts Slightly Higher in Tuesday Trading
2026-06-16 15:08 · Yahoo
European Equities Traded in the US as American Depositary Receipts Increase in Friday Trading; Rise for Week
2026-06-12 15:14 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.